Lilly confirms date and conference call for first-quarter 2025 financial results announcement
Eli Lilly (NYSE: LLY) has scheduled its first-quarter 2025 financial results announcement for May 1, 2025. The company will host a conference call with investors, media, and the general public at 10 a.m. Eastern time to discuss the quarterly performance in detail.
A live webcast of the conference call will be accessible through Lilly's investor relations website, with a replay available after the event.
Eli Lilly (NYSE: LLY) ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 per il 1° maggio 2025. L'azienda terrà una conference call con investitori, media e pubblico generale alle 10:00 ora della costa orientale per discutere nel dettaglio le performance trimestrali.
Una diretta streaming della conference call sarà disponibile sul sito delle relazioni con gli investitori di Lilly, con una registrazione accessibile dopo l'evento.
Eli Lilly (NYSE: LLY) ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 para el 1 de mayo de 2025. La compañía realizará una conferencia telefónica con inversores, medios de comunicación y el público en general a las 10 a.m., hora del este para analizar en detalle el desempeño trimestral.
Una transmisión en vivo de la conferencia telefónica estará disponible a través del sitio web de relaciones con inversionistas de Lilly, con una repetición accesible después del evento.
Eli Lilly (NYSE: LLY)는 2025년 1분기 재무 실적 발표를 2025년 5월 1일로 예정했습니다. 회사는 투자자, 언론 및 일반 대중을 대상으로 동부 표준시 오전 10시에 분기 실적을 자세히 논의하는 컨퍼런스 콜을 진행할 예정입니다.
컨퍼런스 콜은 Lilly 투자자 관계 웹사이트를 통해 생중계되며, 행사 종료 후 다시보기 서비스도 제공됩니다.
Eli Lilly (NYSE : LLY) a prévu l’annonce de ses résultats financiers du premier trimestre 2025 pour le 1er mai 2025. La société organisera une conférence téléphonique avec les investisseurs, les médias et le grand public à 10 heures, heure de l’Est pour discuter en détail des performances trimestrielles.
Un webcast en direct de la conférence téléphonique sera accessible via le site des relations investisseurs de Lilly, avec une rediffusion disponible après l’événement.
Eli Lilly (NYSE: LLY) hat die Bekanntgabe der Finanzergebnisse für das erste Quartal 2025 für den 1. Mai 2025 geplant. Das Unternehmen wird eine Telefonkonferenz mit Investoren, Medien und der Öffentlichkeit um 10 Uhr Eastern Time abhalten, um die Quartalsergebnisse im Detail zu besprechen.
Ein Live-Webcast der Telefonkonferenz wird über die Investor-Relations-Website von Lilly zugänglich sein, mit einer Wiederholung nach der Veranstaltung.
- None.
- None.
The conference call will begin at 10 a.m. Eastern time. Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at https://investor.lilly.com/webcasts-and-presentations. A replay will also be available on the website following the conference call.
About Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram, and LinkedIn. F-LLY
Trademarks and Trade Names
All trademarks or trade names referred to in this press release are the property of the company, or, to the extent trademarks or trade names belonging to other companies are references in this press release, the property of their respective owners. Solely for convenience, the trademarks and trade names in this press release are referred to without the ® and ™ symbols, but such references should not be construed as any indicator that the company or, to the extent applicable, their respective owners will not assert, to the fullest extent under applicable law, the company's or their rights thereto. We do not intend the use or display of other companies' trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.
Refer to: | Ashley Hennessey; gentry_ashley_jo@lilly.com; 317-416-4363 (Media) |
Michael Czapar; czapar_michael_c@lilly.com; 317-617-0983 (Investors) |
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-confirms-date-and-conference-call-for-first-quarter-2025-financial-results-announcement-302430685.html
SOURCE Eli Lilly and Company
FAQ
When will Eli Lilly (LLY) release Q1 2025 earnings?
What time is Eli Lilly's (LLY) Q1 2025 earnings call?
How can investors access LLY's Q1 2025 earnings call?
Will there be a replay available for Eli Lilly's (LLY) Q1 2025 earnings call?
